Committee 1 members began with a weight-of-evidence scheme proposed by Brusick (2) . This system was based on a method of weighted averages of both positive and negative test results from a battery consisting of both in vitro and submammalian assays. Allthough the committee retained the weight-ofevidence portion of the approach, range of assays and the mechanics ofdata handling for the current method have evolved substantially.
There were three primary objectives that committee 1 
Comparison with Other Methods of Data Analysis
Several other investigators have developed or proposed approaches to accomplish many ofthe objectives stated above. One of the earlier uses of the data in this manner was proposed by Squire (3) in which he suggested a semiquantitative approach that estimated carcinogenic potential using a point system for various characteristics ofa chemical. Mutagenicity was highest weighted ofall components ofhis carcinogen prediction scheme.
In the mid-1980s, Waters et al. (4) developed a linear profile of mutagenic activity that illustrated the positive and negative results for all tests conducted on a chemical (Fig. 1 ). This plot, identified as a Genetic Activity Profile (GAP), has undergone several improvements and is currently available with an extensive database on PC-based software (4) . GAPs Nesnow (9) constructed a multifactor ranking scheme for comparing the carcinogenic activity of chemicals. This scheme was produced in collaboration with committee 1 and used a similar process to weight factors that influence potency to the one used in the mutagenicity ranking approach.
Each of the methods described has attributes that make it useful for specific purposes, but the methods are all primarily The results of the evaluation process are expressed in both tabular and graphic formats. The tabular output lists each of thescores identified above, the calculations producing the scores, and reference citations for each of the data entries. The graphic format for ethylene oxide (Fig. 2) is used as an example and can be compared to the GAP graphics in Figure 3 . The data analysis and merging program has continued to evolve as more insight about test performance and data analysis has been gained. Consequently, there have been several versions of the agent scores, which have resulted in slight shifts of the chemical ranking. The system is approaching a point where the committee believes that it is working sufficiently well that final settings for the modifiers can made and the system should be released for general use. Because ofthe design ofthe program, additional information gained during use of the system can be used to "educate" the process by fine tuning the modifiers or by weighting some of the variables (10, 12) .
In developing the process in this manner, certain assumptions were made by the members of the committee: a) there were no established procedures available for using test results to classify chemicals as nonmutagens, but one was needed; b) there was insufficient information available to set weights for different tests. Therefore, all tests were assumed to be equally relevant to the process of determining mutagenic activity; c) both in vitro The committee members considered all ofthese concerns and other likely limitations during the construction ofthe MAP scoring system. Resolution ofall questions was not possible, but the output of the scoring system with the existing data suggested in several cases that the potential limitations did not seriously flaw the evaluation scheme. 
Results
Even with the limitations encountered, the MAP system produced by ICPEMC appears to accomplish many ofthe goals initially stated by the committee. Table 2 is a listing of the rank order 113 chemicals used in constructing the database. Some additional fine tuning of the system is expected, and before final release there could be some minor changes in the rank order of agents. In this latest version, ethanol, with an agent score of -27.70 (Fig. 4) , was the least genetically active agent in the database, and triaziquone (Trenimon) with an agent score of +49.67 (Fig. 5) , was the most genetically active. The rank order, with a few exceptions, seems consistent with an intuitive ranking ofmutagenic activity or with rankings from other experts or expert systems. The agent score might be used in a qualitative manner to establish potential for germ cell hazard. Among the 113 chemicals in the database, 8 have been reported positive in rodent tests for heritable germ cell effects (14, 15) . Seven of the 8 (88%) germ cell mutagens showed positive agent scores. The one compound designated a germ cell mutagen which had a negative agent score was isoniazid (Fig. 6) . A weak positive effect was reported in the mouse heritable translocation assay (1) .
Some consideration has also been given to the use of the agent score as an indicator of carcinogenic potential. Fifteen ofthe 113 chemicals fall into the IARC group I human carcinogens (16) . Thirteen of the 15 (87 %) have positive agent scores ( Table 3) .
The two human carcinogens with negative agent scores are asbestos (Fig. 7) and benzene (Fig. 8) (Fig. 9) , amitrole ( Fig. 10) , and TCDD ( Fig. 11) all exhibited low agent scores. These agents belong to a heterogenous group of chemicals whose mechanisms of carcinogenesis are believed to be other than genotoxic (17) . A subset of the 113 chemicals with these characteristics is listed in A crucial element in this exercise was to compare the mutagenic ranking of chemicals with their ranking as rodent carcinogens. To accomplish this, a parallel system for rank-ordering rodent carcinogens was developed by Nesnow (19) . Once this new database is filled with sufficient chemicals to make a comparison meaningful, the results will be published.
A comprehensive statistical analysis has been performed with the existing database (11) . Several preliminary findings have produced important insight into mutagenicity testing: a) In vitro and in vivo tests appear to respond similarly to a broad range of chemicals. b) Chemicals do not appear to be highly specific for genetic end points (gene mutation, sister chromatid exchange, clastogenicity, cell transformation). Class scores proved to be very congruent with the consensus (Sa) scores for the 113 chemicals. c) Using the 113 chemicals as surrogates for the universe ofchemicals, the range ofagent scores fall generally on a continuous, rather than a bimodal, scale with approximately halfthe chemicals having positive agent scores and half having negative agent scores.
The study and refinement ofthe ICPEMC committee 1 MAP method ofcomplex mutagenicity data evaluation will continue. Its adaptation to data assessment will be enhanced by the availability ofsoftware modified for use on personal computers. Based on the initial experiences with the approach, it is clear that important insights about genetic tests and test batteries will emerge. Whether this approach will break through the current barriers encountered in using genetic test to predict carcinogenicity remains to be seen.
